reported that compared with healthy controls, patients with schizophrenia had higher levels of peripheral complement C3 and C4, and complement C3 and C4 are potential peripheral biomarkers for schizophrenia, which indicates that the role of inflammatory indicators in the diagnosis of mental diseases should be emphasized (27). This evidence concerns the gene C4A and schizophrenia.